Lyphe Clinic has introduced a partnership with Gro-Vida, a licensed medical hashish cultivar. This partnership marks a big step ahead in advancing affected person care and entry to high-quality medical hashish merchandise within the UK.
By forming a strategic partnership with Gro-Vida, the Lyphe Clinic goals to additional strengthen its dedication to offering superior care and uninterrupted entry to medical hashish therapies for its sufferers.
Sophie Gamwell, Basic Supervisor of the Lyphe Clinic, expressed her enthusiasm for the partnership, saying: “We’re delighted to affix arms with Gro-Vida to make sure seamless entry to medical hashish for our sufferers. The assure of a A steady and dependable provide of remedy is important for his or her well-being, and this collaboration permits us to satisfy that dedication.”
Mallory Bodnar, CEO of Gro-Vida, stated: “Our partnership with Lyphe Clinic represents a big step ahead in our shared dedication to reinforce affected person well-being. We’re enthusiastic about this partnership, which embodies our dedication collectively to boost requirements of care. Collectively, we be certain that sufferers have entry to high-quality, constant medical hashish.”
By way of this partnership, Lyphe Clinic sufferers will profit from a streamlined medical hashish provide chain, making certain constant entry to their prescribed drugs. Moreover, the partnership will enable the Lyphe Clinic to train better management over the standard and price of medical hashish supplied to its sufferers, finally enhancing the general affected person expertise.
